Current Liabilities

Other Commercial Liabilities

Kailera Therapeutics Other Commercial Liabilities increased by 23.5% to $46.71M in Q1 2026 compared to the prior quarter.

Analysis

StatementBalance Sheet Statement
SectionCurrent Liabilities
First reportedQ4 2025
Last reportedQ1 2026May 26, 2026
Metric ID: commercial_liabilities_other

Historical Data

2 periods
 Q4 '25Q1 '26
Value$37.84M$46.71M
QoQ Change—+23.5%
Range$37.84M – $46.71M

Frequently Asked Questions

What is Kailera Therapeutics 's other commercial liabilities?
Kailera Therapeutics (KLRA) reported other commercial liabilities of $46.71M in Q1 2026.